Transitioning to Proactive and Data-Driven Safety Management
Pharmacovigilance in 2026: A Shift Toward Proactive Drug Safety Pharmacovigilance (PV) in 2026 is undergoing a major transformation. Growing data volumes, rapid technological advancements, and increasing regulatory expectations are redefining how organizations approach drug safety management. Traditional PV models focused mainly on compliance and adverse event reporting are evolving into more...
0 Commentaires 0 Parts 191 Vue 0 Aperçu
Commandité